Biblio

Export 3139 results:
Author Title [ Type(Asc)] Year
Journal Article
X. - Y. He, Dobkin, C., W Brown, T., and Yang, S. - Y., “3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1487-1497, 2022.
M. Heath, Shellington, E., Titheridge, S., Gill, D. P., and Petrella, R. J., “A 24-Week Multi-Modality Exercise Program Improves Executive Control in Older Adults with a Self-Reported Cognitive Complaint: Evidence from the Antisaccade Task.”, J Alzheimers Dis, vol. 56, no. 1, pp. 167-183, 2017.
S. M. de la Monte, Tong, M., and Wands, J. R., “The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at 'Type 3 Diabetes', Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1381-1390, 2018.
A. A. Sepehry, Lee, P. E., Hsiung, G. - Y. R., B Beattie, L., Feldman, H. H., and Jacova, C., “The 2002 NIMH Provisional Diagnostic Criteria for Depression of Alzheimer's Disease (PDC-dAD): Gauging their Validity over a Decade Later.”, J Alzheimers Dis, vol. 58, no. 2, pp. 449-462, 2017.
J. Jia, Zhang, Y., Shi, Y., Yin, X., Wang, S., Li, Y., Zhao, T., Liu, W., Zhou, A., and Jia, L., “A 19-Year-Old Adolescent with Probable Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 3, pp. 915-922, 2023.
H. - L. Gao, Li, C., Nabeka, H., Shimokawa, T., Wang, Z. - Y., Cao, Y. - M., and Matsuda, S., “An 18-mer Peptide Derived from Prosaposin Ameliorates the Effects of Aβ1-42 Neurotoxicity on Hippocampal Neurogenesis and Memory Deficit in Mice.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1173-92, 2016.
M. T. Fodero-Tavoletti, Okamura, N., Furumoto, S., Mulligan, R. S., Connor, A. R., McLean, C. A., Cao, D., Rigopoulos, A., Cartwright, G. A., O'Keefe, G., Gong, S., Adlard, P. A., Barnham, K. J., Rowe, C. C., Masters, C. L., Kudo, Y., Cappai, R., Yanai, K., and Villemagne, V. L., “18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease.”, Brain, vol. 134, no. Pt 4, pp. 1089-100, 2011.
L. Flem Kalheim, Fladby, T., Coello, C., Bjørnerud, A., and Selnes, P., “[18F]-Flutemetamol Uptake in Cortex and White Matter: Comparison with Cerebrospinal Fluid Biomarkers and [18F]-Fludeoxyglucose.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1595-1607, 2018.
C. M. Lee, Jacobs, H. I. L., Marquié, M., Becker, J. A., Andrea, N. V., Jin, D. S., Schultz, A. P., Frosch, M. P., Gómez-Isla, T., Sperling, R. A., and Johnson, K. A., “18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1691-1702, 2018.
N. Smailagic, Lafortune, L., Kelly, S., Hyde, C., and Brayne, C., “18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1175-1194, 2018.
M. Khosravi, Peter, J., Wintering, N. A., Serruya, M., Shamchi, S. Pourhassan, Werner, T. J., Alavi, A., and Newberg, A. B., “18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.”, J Alzheimers Dis, vol. 70, no. 4, pp. 1197-1207, 2019.
H. Jin Kim, Cho, H., Werring, D. J., Jang, Y. Kyoung, Kim, Y. Jin, San Lee, J., Lee, J., Jun, S., Park, S., Ryu, Y. Hoon, Choi, J. Yong, Cho, Y. Seok, Moon, S. Hwan, Na, D. L., Lyoo, C. Hyoung, and Seo, S. Won, “18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 57, no. 3, pp. 711-716, 2017.
L. Wu, Liu, J., Feng, X., Dong, J., Qin, W., Liu, Y., Wang, J., Lu, J., Chen, K., Wang, Y., and Jia, J., “11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset.”, J Alzheimers Dis, vol. 61, no. 2, pp. 613-618, 2018.
I. A. C. Arnoldussen, Sundh, V., Bäckman, K., Kern, S., Östling, S., Blennow, K., Zetterberg, H., Skoog, I., Kiliaan, A. J., and Gustafson, D. R., “A 10-Year Follow-Up of Adiposity and Dementia in Swedish Adults Aged 70 Years and Older.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1325-1335, 2018.

Pages